TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
The serine protease TMPRSS2 acts as a cofactor for SARS-CoV-2 entry by cleaving the viral spike (S) to initiate fusion. Whether TMPRSS2 has an impact on humoral immune response against S remains poorly characterized. Here, we show that TMPRSS2 impairs antibody binding to S. In S-expressing and infected cells, TMPRSS2 decreases monoclonal antibody (mAb) and immune serum binding, as well as antibody-dependent cellular cytotoxicity (ADCC) induction. Using a panel of 39 mAbs targeting various S regions, we observe that those binding to the S2 subunit are the most affected by TMPRSS2. TMPRSS2 promotes a partial shedding of S1 and changes S2 conformation. This processing reduces Angiotensin-Converting Enzyme 2 (ACE2) binding while increasing cell-cell fusion. We further observe that the capacity of TMPRSS2 to decrease antibody recognition is conserved across coronaviruses and shared with other TMPRSS proteins. However, TMPRSS2 expression in infected cells does not impact significantly virions' infectivity or the antibody recognition, as measured by flow virometry. Collectively, our findings suggest that TMPRSS2 processing of S favors a conformation which is less sensitive to antibody recognition.
Authors
- Andréa Cottignies-Calamarte (ORCID: https://orcid.org/0000-0002-1041-4659)
- Daphné Rageot (ORCID: https://orcid.org/0009-0006-0029-6165)
- Sophie Trouillet‐Assant (ORCID: https://orcid.org/0000-0001-6439-4705)
- Françoise Porrot (ORCID: https://orcid.org/0000-0001-8995-3614)
- Timothée Bruel (ORCID: https://orcid.org/0000-0002-3952-4261)
- Cyril Planchais (ORCID: https://orcid.org/0000-0002-5142-7253)
- Florence Guivel‐Benhassine (ORCID: https://orcid.org/0000-0003-3410-5671)
- Isabelle Staropoli (ORCID: https://orcid.org/0000-0001-8637-4545)
- Ignacio Fernández (ORCID: https://orcid.org/0000-0001-8355-580X)
- Olivier Schwartz (ORCID: https://orcid.org/0000-0002-0729-1475)
- Hugo Mouquet (ORCID: https://orcid.org/0000-0002-4230-610X)
- Pierre Rosenbaum (ORCID: https://orcid.org/0000-0001-9287-8985)
- Eva Thuillier
- Felix Rey (ORCID: https://orcid.org/0000-0001-9082-780X)
- Martin Jungbauer-Groznica (ORCID: https://orcid.org/0000-0003-1223-5491)
- Amelie Wileveau (ORCID: https://orcid.org/0009-0005-3850-2924)
- Alejandro De Cruz (ORCID: https://orcid.org/0009-0009-2745-1032)
- Mateo Kryzpow
- Julian Buschrieser
- Irène Misguich
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Normale Supérieure Paris-Saclay (FR)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Hospices Civils de Lyon (FR)
- Immunité et Cancer (FR)
- Hôpital Lyon Sud (FR)
- Institut de Recherche Vaccinale (FR)
- Université Jean Monnet (FR)
- Université Jean Monnet (FR)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1371/journal.ppat.1014799
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Institut Pasteur
- Hospices Civils de Lyon
- Fondation Hospices Civils de Lyon